Paris and Tarrytown, NY, September 27, 2024. The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment of adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an…Original Article
Dupixent Approved in the US as the First-Ever Biologic Medicine for Patients with COPD
